Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: hallucination; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 30May2021 (at the age of 38-year-old) as 1st dose, single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication included levothyroxine sodium (L-THYROXIN [LEVOTHYROXINE SODIUM]). The patient experienced hallucination two days after vaccination (01Jun2021). The outcome of the event was unknown. Information on the lot/batch number has been requested.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166